Search - tctmd.com

Displaying 341 - 360 of 423

Sort: Relevancy | Date

Presentation TCT 2013

Restenosis after Left Main PCI: Frequency, Patterns and Treatment (with Case Vignettes)

Presenter: Adrian Banning

October 28, 2013

Presentation TCT 2013

Predictors of Restenosis and Reocclusion After Successful CTO PCI in the DES Era: Insights from the Florence CTO Registry

Presenter: David Antoniucci

October 28, 2013

Presentation TCT 2013

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Presenter: Bruno Scheller

October 28, 2013

Presentation TCT 2013

Frequency and Time Course of DES Restenosis and Stent Thrombosis: Latest Insights from Randomized Trials and the "Real World"

Presenter: Robert Byrne

October 28, 2013

Presentation TCT 2013

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

DES Restenosis: Evaluation and Treatment Options

Presenter: Fernando Alfonso

October 28, 2013

Presentation TCT 2013

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Presenter: Thomas Zeller

October 27, 2013

Presentation TCT 2013

Attacking the Adventitia: Rationale, Feasibility, and Early Signals of Efficacy for Restenosis

Presenter: Christopher Owens

October 27, 2013

Presentation

Short- vs. Long-term Duration of DAPT in Patients Treated for In-Stent Restenosis

Presenter: Gianluca Campo

October 23, 2013

Presentation

A Randomized Comparison of Paclitaxel-coated Balloon Catheter With Conventional Balloon Angioplasty In Patients With BMS, DES Restenosis

Presenter: Seiji Habara

September 23, 2013

Presentation

Higher Risk of Recurrent Ischemic Events in Patients with Intracranial In-Stent Restenosis

Presenter: M. Jin

August 27, 2013

Presentation

Systematic Review of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis

Presenter: Tarun W. Dasari

August 21, 2013

Presentation

Clinical Outcomes of the Resolute ZES in Patients With In-Stent Restenosis

Presenter: Gert Richardt

August 14, 2013

Presentation

Differential Impact of Cilostazol on Restenosis According to Implanted Stent Type

Presenter: 101420|Se-Whan Lee

August 07, 2013

Presentation SOLACI 2013

Dealing with In-Stent Restenosis: Mechanisms, Predictors, and Clinical Implications

Presenter: Roxana Mehran

July 25, 2013

Presentation TCT Russia 2013

How to Treat InDES Restenosis: DES? Balloon? DEB?

Presenter: B. Chevalier

June 09, 2013

Presentation

Angioplasty Following Carotid Stent Deployment Reduces the Risk of Restenosis and May or May Not Increase the Risk of Procedure-Related Stroke

Presenter: Mahmoud B. Malas

May 09, 2013

Presentation

Colchicine Treatment for Prevention of In-BMS Restenosis in Diabetics

Presenter: S. Deftereos

April 17, 2013

Presentation Fellows 2013

Stent Complications: Restenosis and Thrombosis

Presenter: Ajay Kirtane

April 15, 2013

Presentation

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Presenter: T. Zeller

April 03, 2013

Advertisement

Restenosis after Left Main PCI: Frequency, Patterns and Treatment (with Case Vignettes)

Predictors of Restenosis and Reocclusion After Successful CTO PCI in the DES Era: Insights from the Florence CTO Registry

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Frequency and Time Course of DES Restenosis and Stent Thrombosis: Latest Insights from Randomized Trials and the "Real World"

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

DES Restenosis: Evaluation and Treatment Options

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Attacking the Adventitia: Rationale, Feasibility, and Early Signals of Efficacy for Restenosis

Short- vs. Long-term Duration of DAPT in Patients Treated for In-Stent Restenosis

A Randomized Comparison of Paclitaxel-coated Balloon Catheter With Conventional Balloon Angioplasty In Patients With BMS, DES Restenosis

Higher Risk of Recurrent Ischemic Events in Patients with Intracranial In-Stent Restenosis

Systematic Review of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis

Clinical Outcomes of the Resolute ZES in Patients With In-Stent Restenosis

Differential Impact of Cilostazol on Restenosis According to Implanted Stent Type

Dealing with In-Stent Restenosis: Mechanisms, Predictors, and Clinical Implications

How to Treat InDES Restenosis: DES? Balloon? DEB?

Angioplasty Following Carotid Stent Deployment Reduces the Risk of Restenosis and May or May Not Increase the Risk of Procedure-Related Stroke

Colchicine Treatment for Prevention of In-BMS Restenosis in Diabetics

Stent Complications: Restenosis and Thrombosis

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content